Boenning & Scattergood, Inc. Acadia Pharmaceuticals Inc Call Options Transaction History
Boenning & Scattergood, Inc.
- $622 Million
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
353Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$997 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$353 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$280 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$199 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$163 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.76B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...